Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Dr. Reddy’s Laboratories has announced the launch of Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem® (ramelteon, 8 mg) Tablets.
read more
Uman Diagnostics and Bio-Techne announced a strategic License and Supply Agreement for the antibodies used in the quantification of Nf-L on the ProteinSimple™-branded Ella™ immunoassay platform.
read more
Arkivum has achieved pharma-level compliance with the award of ISO 9001:2015 certification, demonstrated alignment with data-related GxP regulations.
read more
OnKure entered into an exclusive license and option agreement with KDAc Therapeutics to support the continued development of KDAc’s selective histone deacetylase 3 (HDAC3) inhibitor program.
read more
Lubrizol announces the acquisition of Bavaria Medizin Technologie GmbH, a designer and manufacturer of both intravascular and nonvascular devices, by its German subsidiary Lubrizol Deutschland GmbH.
read more
Rising Pharmaceuticals announced the U.S. launch & commercial shipment of a generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths.
read more
Amgen announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus.
read more
BIA Separations announced it is collaborating with AveXis to enhance the commercial purification process for its gene therapy pipeline, beginning with Zolgensma®.
read more
Marken announced they have acquired HRTL based in Italy along with two additional companies in Austria and Hungary under the respective names of HETO and Der Kurier.
read more
Pall Corporation has been chosen by Servier as an exclusive technology and services provider for their Gidy, France biomanufacturing facility.
read more
Dr. Reddy’s announced the launch of Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets, USP.
read more
Sosei Group announces Formosa Pharmaceuticals has received approval from the FDA of its IND application for APP13007 to commence a first-in-human clinical trial in the United States.
read more
Boehringer Ingelheim and Bridge Biotherapeutics announced they are entering into a new collaboration and license agreement with the goal of developing autotaxin inhibitor BBT-877.
read more
CenExel Clinical Research announced the creation of their Centers of Excellence company, which unites four clinical research units in the country to design and execute Phase I-IV trials.
read more
Catalent has appointed Ricardo Pravda as Senior Vice President and Chief Human Resources (HR) Officer.
read more